S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
about
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
S9717 Tirapazamine Plus Cispla ...... or Refractory Cervical Cancer
@en
type
label
S9717 Tirapazamine Plus Cispla ...... or Refractory Cervical Cancer
@en
prefLabel
S9717 Tirapazamine Plus Cispla ...... or Refractory Cervical Cancer
@en
P6153
P1476
Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer
@en
P3098
NCT00003369
P580
1998-08-01T00:00:00Z
P582
2003-10-01T00:00:00Z